Comparison of different HMG-CoA reductase inhibitors
Authors:
- 1 January 1991
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 40 (S1) , S27-S32
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: The finnish multicenter studyThe American Journal of Cardiology, 1988
- Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemiaAtherosclerosis, 1988
- A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. The Lovastatin Study Group III1988
- Hypolipidemic effects of HMG-CoA reductase inhibitors in patients with hypercholesterolemiaThe American Journal of Cardiology, 1987
- New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase.Circulation, 1987
- Long term administration of lovastatin in the treatment of hypercholesterolaemiaEuropean Heart Journal, 1987
- Therapeutic response to lovastatin (mevinolin) in nonfamilial hypercholesterolemia. A multicenter study. The Lovastatin Study Group II1986
- A Receptor-Mediated Pathway for Cholesterol HomeostasisScience, 1986
- Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemiaThe American Journal of Cardiology, 1986
- Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.Proceedings of the National Academy of Sciences, 1983